REVERSIBLE DECREASE OF SURFACE BETA(2)-ADRENOCEPTOR NUMBER AND RESPONSE IN LYMPHOCYTES OF PATIENTS WITH PHEOCHROMOCYTOMA

被引:14
作者
CASES, A
BONO, M
GAYA, J
JIMENEZ, W
CALLS, J
ESFORZADO, N
RIVERA, F
REVERT, LL
机构
[1] HOSP CLIN BARCELONA,NEPHROL UNIT,E-08036 BARCELONA,SPAIN
[2] HOSP CLIN BARCELONA,HORMONOL UNIT,E-08036 BARCELONA,SPAIN
关键词
PHEOCHROMOCYTOMA; SURFACE BETA(2)-ADRENOCEPTORS; CGP12177; CATECHOLAMINES; BETA(2)-ADRENERGIC RESPONSE;
D O I
10.3109/10641969509037423
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To study the effect of chronic exposure to elevated plasma catecholamines on surface beta(2)-adrenoceptor density, we measured these receptors in the lymphocytes of 9 patients with pheochromocytoma as well as in 27 healthy control subjects. Binding experiments were performed on intact lymphocytes Using the hydrophilic ligand [H-3]-CGP12177. Lymphocyte beta(2)-adrenergic response was also measured in three patients. beta(2)-adrenoceptor density (p < 0.01), and isoproterenol-stimulated increase in cAMP were reduced in patients with pheochromocytoma. Both parameters normalized (p < 0.05) when patients were reevaluated 4 weeks after tumor removal, coinciding with normalization of plasma catecholamine levels. B-2-adrenoceptor density inversely correlated to log of plasma epinephrine (r=-0.95, p < 0.01) and to log of plasma norepinephrine (r=-0.58, p < 0.05) in patients. We conclude that chronic catecholamine excess induces a decrease of lymphocyte beta(2)-adrenoceptor surface number and response that is reversible upon normalization of plasma catecholamine levels. This regulation is mainly dependent on plasma levels of the hormone epinephrine, but norepinephrine may also play a regulatory role at supraphysiological levels.
引用
收藏
页码:537 / 549
页数:13
相关论文
共 29 条
[1]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[2]  
BRAVO E, 1990, HYPERTENSION S1, V15, pS128
[3]   ALPHA AND BETA-ADRENERGIC-RECEPTOR ACTIVITY IN CIRCULATING BLOOD-CELLS OF PATIENTS WITH IDIOPATHIC ORTHOSTATIC HYPOTENSION AND PHEOCHROMOCYTOMA [J].
CHOBANIAN, AV ;
TIFFT, CP ;
SACKEL, H ;
PITRUZELLA, A .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 1982, 4 (4-5) :793-806
[4]   AGONIST-INDUCED REDISTRIBUTION OF BETA-ADRENERGIC RECEPTORS ON INTACT HUMAN MONONUCLEAR LEUKOCYTE REDISTRIBUTED RECEPTORS ARE NONFUNCTIONAL [J].
DEBLASI, A ;
LIPARTITI, M ;
MOTULSKY, HJ ;
INSEL, PA ;
FRATELLI, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (06) :1081-1088
[5]   INVIVO REGULATION OF BETA-ADRENERGIC RECEPTORS ON HUMAN MONONUCLEAR LEUKOCYTES - ASSESSMENT OF RECEPTOR NUMBER, LOCATION, AND FUNCTION AFTER POSTURE CHANGE, EXERCISE, AND ISOPROTERENOL INFUSION [J].
DEBLASI, A ;
MAISEL, AS ;
FELDMAN, RD ;
ZIEGLER, MG ;
FRATELLI, M ;
DILALLO, M ;
SMITH, DA ;
LAI, CYC ;
MOTULSKY, HJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (04) :847-853
[6]   DIFFERENCES IN LEFT-VENTRICULAR STRUCTURAL AND FUNCTIONAL-CHANGES BETWEEN PHEOCHROMOCYTOMA AND ESSENTIAL-HYPERTENSION - ROLE OF ELEVATED CIRCULATING CATECHOLAMINES [J].
FOUADTARAZI, FM ;
IMAMURA, M ;
BRAVO, EL ;
ROSSI, G ;
NAGI, HK ;
LIN, WW ;
CRESSMAN, M ;
WICKER, P .
AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (03) :134-140
[7]   REGULATION OF HUMAN-LEUKOCYTE BETA-RECEPTORS BY ENDOGENOUS CATECHOLAMINES - RELATIONSHIP OF LEUKOCYTE BETA-RECEPTOR DENSITY TO THE CARDIAC SENSITIVITY TO ISOPROTERENOL [J].
FRASER, J ;
NADEAU, J ;
ROBERTSON, D ;
WOOD, AJJ .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (06) :1777-1784
[8]   DECREASED BETA-ADRENERGIC RECEPTORS ON POLYMORPHONUCLEAR LEUKOCYTES AFTER ADRENERGIC THERAPY [J].
GALANT, SP ;
DURISETI, L ;
UNDERWOOD, S ;
INSEL, PA .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (17) :933-936
[9]  
Halawa B, 1991, Kardiol Pol, V35, P340
[10]  
HARDEN TK, 1983, PHARMACOL REV, V35, P5